Nonobstructive CAD: Recognition needed, treatment options sought
The role of lipid-lowering therapies: A look at the guidelines
Lipid Forum II Highlights
The Patient with Familial Hypercholesterolemia
Boston Scientific has begun enrollment of the REDUCE-HTN: REINFORCE study, which will evaluate the efficacy and safety of renal denervation in patients with hypertension, according to a press release.
The randomized, sham-controlled, multicenter study will assess the Vessix Renal Denervation System in 100 patients.
This activity is supported by an educational grant from AstraZeneca.
Nathaniel Reichek, MD: A pioneer in the development of cardiac MRI
This feature offers timely executive summaries of the most relevant journals in cardiology.
Snapshot summaries of recent study results in cardiology.
Your central portal for information presented at ACC 2015.
Your resource for news and videos from SCAI 2014.
This exclusive Healio resource provides you a comprehensive window into what your colleagues and key opinion leaders are saying about current and future drugs and devices and their impact on patient outcomes.
Related story »
View past polls »
Search Healio's robust listing of national and international medical meetings.
©2015 All Rights Reserved.